These results indicated that inhibiting Gli1 expression in CCl4/2-AAF-treated rats significantly repressed HPC activation, proliferation, and differentiation into reactive cholangiocytes, and meanwhile ameliorated liver fibrosis. Here, GLI1 is linked to Hepatic fibrosis.